aetna coverage for glp-1 Does Cover Mounjaro Weight Loss? what glp 1 does aetna
Description
Mounjaro was approved in 2022 for type 2 diabetes, while Zepbound was approved in 2023 specifically for chronic weight management

Tirzepatide has been studied extensively across multiple large-scale clinical trial programs

However, its important to note: Weight management can be a valuable secondary outcome for people with T2DM, as it often improves insulin sensitivity, lowers cardiovascular risk, and enhances overall metabolic health 4 , 10
In animal studies SGLT2 inhibitors were excreted in breast milk and affected neonatal growth, but human data are not available

SN Comprehensive Clinical Medicine 2022 5:1 [Internet]
